Glycemic variability: Clinical implications
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Glycemic control and its benefits in preventing microvascular diabetic complications are convincingly proved by various prospective trials. Diabetes control and complications trial (DCCT) had reported variable glycated hemoglobin (HbA1C) as a cause of increased microvascular complications in conventional glycemic control group versus intensive one. However, in spite of several indirect evidences, its link with cardiovascular events or macrovascular complications is still not proved. Glycemic variability (GV) is one more tool to explain relation between hyperglycemia and increased cardiovascular risk in diabetic patients. In fact GV along with fasting blood sugar, postprandial blood sugar, HbA1C, and quality of life has been proposed to form glycemic pentad, which needs to be considered in diabetes management. Postprandial spikes in blood glucose as well as hypoglycemic events, both are blamed for increased cardiovascular events in Type 2 diabetics. GV includes both these events and hence minimizing GV can prevent future cardiovascular events. Modern diabetes management modalities including improved sulfonylureas, glucagon like peptide-1 (GLP-1)-based therapy, newer basal insulins, and modern insulin pumps address the issue of GV effectively. This article highlights mechanism, clinical implications, and measures to control GV in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310 · cited 3×
“There is a strong scientifi c evidence to suggest that oxidative stress is related to glycemic excursions,[1-5,39] however, the interventional studies have not been able to consistently demonstrate the relationship and moreover antioxidant therapy did not reduce the vascular complication.[39-41] Recently identifi cati…”
BackgroundResultPostprandial Hyperglycemia and Diabetes Complications
Ceriello, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.1 · Cited by 945
Drucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., & Habener, J. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3434 · Cited by 903 · cited 1×
“GLP-1 analogues Glucose-dependent insulinotropic peptide (GIP) and GLP-1 activation of incretin receptors on -cells increases insulin release in response to glucose and has additional benefi ts of enhanced glucose disposal in peripheral tissues and protection against ischemia/reperfusion injury.[79,80] In critical ca…”
BackgroundOxidative stress and diabetic cardiovascular complications
Jay, D., Hitomi, H., & Griendling, K. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.06.018 · Cited by 464
Esposito, K., Giugliano, D., Nappo, F., & Marfella, R. (2004) · Circulation · doi:10.1161/01.cir.0000134501.57864.66 · Cited by 440
Insulin glargine or NPH combined with metformin in type 2 diabetes: The LANMET study
Yki-Järvinen, H., Kauppinen-Mäkelin, R., Tiikkainen, M., Vähätalo, M., Virtamo, H., Nikkilä, K., Tulokas, T., Hulme, S., Hardy, K., McNulty, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0132-0 · Cited by 434 · cited 2×
“In an another study LANMET[74] the mean A1c level dropped by 2% from base line to end point, it was commented by Monnier et al.”
BackgroundA1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2008) · Diabetes Care · doi:10.2337/dc08-0864 · Cited by 420
Avignon, A., Radauceanu, A., & Monnier, L. (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1822 · Cited by 363
Raz, I., Wilson, P. W. F., Strojek, K., Kowalska, I., Bozikov, V., Gitt, A. K., Jermendy, G., Campaigne, B. N., Kerr, L., Milicevic, Z., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1671 · Cited by 351 · cited 1×
“The occurrence of various microvascular and macrovascular complications in diabetes is attributed by various studies to hyperglycemia and dysglycemia (peaks and nadirs).[7-11] Several pathophysiological mechanisms were put forward,[12,13] unifying the two main mechanisms: Excessive protein glycation end products and a…”
BackgroundPlasma Glucose Levels Throughout the Day and HbA1c Interrelationships in Type 2 Diabetes
Bonora, E., Calcaterra, F., Lombardi, S., Bonfante, N., Formentini, G., Bonadonna, R. C., & Muggeo, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2023 · Cited by 235
Does Glycemic Variability Impact Mood and Quality of Life?
Penckofer, S., Quinn, L., Byrn, M., Ferrans, C., Miller, M., & Strange, P. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0191 · Cited by 138
Cox, D. J., Kovatchev, B. P., Julian, D. M., Gonder-Frederick, L. A., Polonsky, W. H., Schlundt, D. G., & Clarke, W. L. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989471 · Cited by 137 · cited 2×
“[44] Glucose variability was mentioned as measure of predictor of future severe hypoglycemia than HbA1c by Cox et al.[45] In a study by Kilpatrick et al. using datasets of the DCCT found that glucose variability, calculated as SD of SMB and MAGE was independently predictive of hypoglycemia just like MBG and other stud…”
BackgroundDiet-Induced Weight Loss Is Associated with an Improvement in β-Cell Function in Older Men
Utzschneider, K. M., Carr, D. B., Barsness, S. M., Kahn, S. E., & Schwartz, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031827 · Cited by 73 · cited 1×
“Life style measures Diet-induced weight loss can signifi cantly improve not only insulin sensitivity but also -cell function, capable of reducing glucose levels and delaying the progression from impaired glucose tolerance (IGT) to diabetes.[65,66] Recently a research study on diet of high glycemic meal with pistachio…”
BackgroundKendall, C. W. C., Josse, A. R., Esfahani, A., & Jenkins, D. J. A. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.12 · Cited by 69
Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargine
McCall, A. L., Cox, D. J., Brodows, R., Crean, J., Johns, D., & Kovatchev, B. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0107 · Cited by 46 · cited 6×
“In another study, Exenatide in comparison with insulin glargine had better postprandial glucose profile and signifi cant reduction in ADRR, a sensitive predictor of either hyper-hypoglycemia despite similar reductions in A1C.[33] Exenatide had better effect on reducing GV when compared with glimerpiride treatment.”
BackgroundResultInfluential
Cited by
Glycemic Variability: How Do We Measure It and Why Is It Important?
Suh, S., & Kim, J. H. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.273 · Cited by 439
Standing-based office work shows encouraging signs of attenuating post-prandial glycaemic excursion
Buckley, J. P., Mellor, D. D., Morris, M., & Joseph, F. (2014) · Occupational and Environmental Medicine · doi:10.1136/oemed-2013-101823 · Cited by 124
Minimizing Glycemic Fluctuations in Patients with Type 2 Diabetes: Approaches and Importance
Dandona, P. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0372 · Cited by 67
“Specifically, glycemic fluctuations are characterized by variations in blood glucose levels (glycemic excursions) and include hypoglycemic events and postprandial hyperglycemia.(14) Since HbA1c does not reflect these short-term oscillations, patients with T2D may achieve a target HbA1c while still experiencing marked…”
BackgroundKasthuri, S., Poongothai, S., Anjana, R. M., Selvakumar, J., Muthukumar, S., Kayalvizhi, S., Tariq, S., Honey, E., Gupta, P. K., Venkatesan, U., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0484 · Cited by 13
Pratley, R. E., Rosenstock, J., Heller, S. R., Sinclair, A., Heine, R. J., Kiljański, J., Brusko, C. S., Duan, R., & Festa, A. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818776993 · Cited by 13
Metadata
- Authors
- Kota, S., Satya Krishna, S., & Modi, K.
- Venue
- Indian Journal of Endocrinology and Metabolism
- Publisher
- Medknow
- Published
- 2013
- Volume
- 17
- Issue
- 4
- Pages
- 611
- ISSN
- 2230-8210 (ISSN-L)
- OpenAlex
- W1971567893
- Cited by
- 74
- References
- 18
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.